1. Academic Validation
  2. Discovery of natural alkaloids as potent and selective inhibitors against human carboxylesterase 2

Discovery of natural alkaloids as potent and selective inhibitors against human carboxylesterase 2

  • Bioorg Chem. 2020 Dec;105:104367. doi: 10.1016/j.bioorg.2020.104367.
Yi-Shu Zhao 1 Xing-Kai Qian 1 Xiao-Qing Guan 1 Pei-Fang Song 1 Yun-Qing Song 1 Rong-Jing He 1 Meng-Ru Sun 1 Xiu-Yang Wang 1 Li-Wei Zou 2 Guang-Bo Ge 3
Affiliations

Affiliations

  • 1 Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • 2 Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Electronic address: [email protected].
  • 3 Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Electronic address: [email protected].
Abstract

Human Carboxylesterase 2A (hCES2A), one of the most important serine hydrolases, plays crucial roles in the hydrolysis and the metabolic activation of a wide range of esters and amides. Increasing evidence has indicated that potent inhibition on intestinal hCES2A may reduce the excessive accumulation of SN-38 (the hydrolytic metabolite of irinotecan with potent cytotoxicity) in the intestinal tract and thereby alleviate the intestinal toxicity triggered by irinotecan. In this study, more than sixty natural Alkaloids have been collected and their inhibitory effects against hCES2A are assayed using a fluorescence-based biochemical assay. Following preliminary screening, seventeen Alkaloids are found with strong to moderate hCES2A inhibition activity. Primary structure-activity relationships (SAR) analysis of natural Isoquinoline Alkaloids reveal that the benzo-1,3-dioxole group and the aromatic pyridine structure are beneficial for hCES2A inhibition. Further investigations demonstrate that a steroidal alkaloid reserpine exhibits strong hCES2A inhibition activity (IC50 = 0.94 μM) and high selectivity over other human serine hydrolases including hCES1A, Dipeptidyl Peptidase IV (DPP-IV), butyrylcholinesterase (BChE) and Thrombin. Inhibition kinetic analyses demonstrated that reserpine acts as a non-competitive inhibitor against hCES2A-mediated FD hydrolysis. Molecular docking simulations demonstrated that the potent inhibition of hCES2A by reserpine could partially be attributed to its strong σ-π and S-π interactions between reserpine and hCES2A. Collectively, our findings suggest that reserpine is a potent and highly selective inhibitor of hCES2A, which can be served as a promising lead compound for the development of more efficacious and selective alkaloids-type hCES2A inhibitors for biomedical applications.

Keywords

Alkaloids; Human carboxylesterase 2A (hCES2A); Inhibitor; Reserpine.

Figures
Products